韭菜巴菲特

$Apple(AAPL.US)

Context: Apple has been moving around recently, but I’m still comfortable holding the position for the longer term. Today, my Apple holding is slightly back in the green at +0.44%, with the market price at 311.30 compared with my cost of 309.589.

My trade: I’m holding my AAPL position and not rushing to take profit. With Apple’s long-term growth potential, I prefer to stay patient and monitor the price action before deciding whether to add or trim.

Takeaway: Small gains are still encouraging — next time, I’d focus even more on patience instead of reacting to short-term price movements. 🍎📈

$SPCX 2X Long ETF(SPCH.US)

Context: SPCH has been under pressure recently, and my position is currently sitting at -4.60%. The market price is 9.005 compared with my cost of 9.440. I’m expecting volatility to remain high, so I’m focusing more on the overall market direction rather than reacting to every short-term move.

My trade: I’m adding andholding my position for now instead of cutting it purely because of the current loss. Since this is a 2X leveraged ETF, I’m keeping the position size and risk in mind while waiting for a potential recovery.

Takeaway: Next time, I’d be more disciplined about my entry and position sizing, especially when trading leveraged products. 📊

$Circle(CRCL.US)Circle (CRCL) is continuing to move in the right direction, with my position currently showing a +8.65% unrealised gain. My average cost is around 71.26, compared with the current market price of 77.47. Still holding patiently rather than chasing short-term price movements. There will definitely be ups and downs along the way, but I’m focusing more on the long-term potential and letting the investment thesis play out. 📈

$Oracle(ORCL.US)Oracle is definitely testing my patience here 😅 Currently sitting at a -17.39% P/L, with the market price at 148.570 versus my average cost of 180.032. The chart has been quite a journey, but I’m trying not to let short-term volatility change my original investment view. For now, I’m staying patient and watching Oracle’s fundamentals, growth potential and future earnings closely. Sometimes the hardest part of investing is simply waiting for the thesis to play out. 📈

$SPCX 2X Long ETF(SPCH.US)

Another position I’m patiently holding through the volatility. SPCX 2X Long ETF is currently down 4.94%, with the market price at 9.000 versus my average cost of 9.468. Definitely not the green screen I wanted to see, but short-term fluctuations are part of the game. I’m keeping my focus on the bigger picture rather than reacting emotionally to every dip. Let’s see if this position can turn around from here. 📈

$Unitedhealth(UNH.US)UnitedHealth closed at $401.67, down 13% from its July high of $461.62 but up 58% from its May 2025 crash low. Q2 2026 EPS surged 61.5% YoY to $6.04 with FCF nearly doubling, though revenue growth flattened near zero. Multiple daily oscillators flash oversold with Bollinger lower-band support at $396 being tested. Forward PE sits at 25.4x, near its 5-year median, while dividend yield has climbed to a 5-year high of 2.24%.

$Apple(AAPL.US)

Despite reporting record Q3 revenue and EPS, shares continue to sell off — the market is pricing in conservative Q4 guidance rather than celebrating the beat. At ~34x forward earnings, the valuation leaves minimal room for error, and net institutional outflows of -\$88.75M signal caution. Volume ratio at 0.77 suggests below-average participation, while the 52-week high of \$344.27 now sits 12% overhead as resistance.

Whether the -8.9% pullback finds support near \$300 or if guidance concerns push it lower toward the \$280–290 zone.

$Circle(CRCL.US)Finally turned green! 🟢📈 After holding through the volatility, my CRCL position is now showing a +2.02% gain, with the market price at 72.76 versus my average cost of 71.26. It’s still a small gain, but seeing the position move back into profit feels good. I’m staying patient and watching the price action closely. Hopefully this is just the beginning of a stronger recovery. 💪📊 #CRCL #Circle #TradeShowcase #Investing

$Lion-phillip S-Reit(CLR.SG)Lion-Phillip S-REIT CLR is currently slightly underwater at -1.20%, with my cost at 0.829 versus the market price of 0.819. Still holding patiently as I view REITs as a longer-term income and diversification play. The short-term price movement isn’t ideal, but I’m focusing more on the overall yield, stability and potential recovery rather than reacting to a small unrealised loss. 📈 #TradeShowcase

$Oracle(ORCL.US)Oracle has been a challenging position so far, currently sitting at -16.59%, with the market price around $150.08 versus my average cost of $180.03. 📉

Despite the drawdown, I’m staying patient and keeping my focus on the bigger picture rather than reacting emotionally to short-term volatility. Oracle remains a company I’m willing to hold through the ups and downs, and I’ll continue monitoring its fundamentals, growth prospects, and future catalysts. The current loss is uncomfortable, but the investment thesis isn’t necessarily broken. 💪📊

$Unitedhealth(UNH.US)UnitedHealth (UNH) is showing a solid recovery in my portfolio, currently sitting at +18.44% with the market price around $407.08 versus my average cost of $343.33. I’m still holding with a longer-term view, as I believe the recent weakness created an attractive entry point. The recovery has been encouraging, but I’m staying patient and watching the company’s fundamentals and future growth closely. #TradeShowcase

$Circle(CRCL.US)Circle (CRCL) is still testing my patience 😅 Currently sitting at around -6.26%, with the market price at 66.67 versus my average cost of 71.26. I’m not rushing to cut the position just because of short-term weakness. I’m watching how Circle performs from here and whether the long-term thesis can still play out. For now, patience and discipline—let’s see if CRCL can turn this red position back green. 📉➡️📈 #TradeShowcase #CRCL #Circle #USStocks #Investing

$Netflix(NFLX.US)Netflix remains a challenging position, currently sitting at -12.19%, with the market price at 73.69 versus my average cost of 83.963. The recent price action has been weak, but I’m staying patient and keeping a longer-term view rather than reacting emotionally to short-term movements. I’ll continue monitoring the fundamentals and valuation closely, and if the thesis remains intact, I’m prepared to hold through the volatility. 📉💪

$Unitedhealth(UNH.US)Holding UnitedHealth through the volatility is finally paying off. My position is now sitting at +20.38%, and this is a great reminder that patience often rewards investors who stick to their conviction instead of reacting to every short-term headline. 📈

I’m not rushing to celebrate or lock in profits just yet. I’ll continue monitoring earnings, business fundamentals, and the overall healthcare sector before making my next move. Every successful investment reinforces the importance of having a plan, managing risk, and letting time work in your favor. Wishing everyone green portfolios and disciplined investing! 💪📊🚀

$Oracle(ORCL.US)Oracle has been under pressure, with my position currently showing a -17.65% P/L, as the market price of 148.193 remains well below my average cost of 180.032. Despite the drawdown, I’m still holding the position and monitoring Oracle’s fundamentals, cloud growth, AI-related opportunities, and overall market sentiment. The recent weakness is definitely painful, but I’m taking a longer-term view and looking for signs of stabilization before making my next move. 📉💪

$Netflix(NFLX.US)Netflix is definitely testing my patience 😭 Down 12.98% with my average cost at $83.96 while the market price sits around $73.04. 📉

Still holding and staying patient. The long-term story remains interesting, but this drawdown is a good reminder that even strong companies can go through painful pullbacks. Now the question is whether to hold, average down, or wait for a clearer reversal. 👀

Looking for a clearer path ahead let’s go

$Apple(AAPL.US) Apple is currently sitting at a small unrealized loss of 0.22%, with the market price at $308.91 compared with my average cost of $309.93. 🍎📉 It’s barely a move, so I’m not too concerned at this stage. I’m still watching Apple closely, especially its ability to maintain momentum around the current price level. For now, I’m staying patient rather than reacting to a small short-term fluctuation. Let’s see whether AAPL can regain strength and push higher from here. 📈💪

$Defiance Daily Target 2X Short MU ETF(MUZ.US)Added more to my MU short position as I continue to hold a bearish view on the stock. The position is currently showing a -4.33% P/L, with the market price at 13.465 compared with my average cost of 14.075.

The trade has moved against me so far, but I’m using the recent price action as an opportunity to build the position gradually rather than rushing into a full-size trade. My thesis remains focused on the possibility of further downside in MU, while I’ll continue monitoring momentum, market sentiment, and key price levels closely.

$Defiance Daily Target 2X Short MU ETF(MUZ.US)

I was trying to take a short position on MU because I believe the stock could face downside pressure, but today’s strong AI and tech rally completely went against my position. The broad market momentum pushed MU higher and resulted in a 21.86% loss in just one day. This is a good reminder that even when I have conviction in my bearish thesis, short positions can move against me very quickly. I’ll continue monitoring the market and reassessing the trade instead of letting emotions take over.

$Apple(AAPL.US)Staying patient with my $Apple(AAPL.US) position and it’s now sitting at +9.39%. 🍏 Apple’s strength continues to come from its loyal ecosystem, consistent cash flow, and growing services business. While short-term volatility is always possible, I believe quality companies tend to reward long-term investors. No need to chase every market move—sometimes the best strategy is simply to hold, stay disciplined, and let compounding do the work. Looking forward to seeing how Apple’s AI initiatives and future product launches contribute to long-term growth. 🚀📈

$Unitedhealth(UNH.US)UNH closed at $419.08 on Friday, sitting right on the 30-day MA (~$419) after pulling back from the $434 Bollinger upper band. A few things I’m watching closely:

Technicals are flashing caution, but also potential support. KDJ is deeply oversold (K at 24, J at 9), ARBR shows an extremely oversold BR reading, and the PSY indicator just broke below its moving average — short-term selling pressure is real. However, MACD remains above the zero line, meaning the broader uptrend hasn’t fully reversed yet.

The setup matters. Price is now testing the 30-day MA as support. If this level holds, it could be a solid re-entry zone for those who missed the prior leg up. A break below $415 (Bollinger lower band) would change the picture.